• Kuba Kingdom

    Democratic Republic of the Congo (DRC)

    EXMceuticals, through a subsidiary, holds a license in the Kuba Kingdom, Democratic Republic of Congo, for the cultivation of cannabis and hemp, and processing and export of high-grade pharmaceutical cannabinoid ingredients. For its Kuba plantation, EXM has 10,000 acres of organic farmland and expansion rights representing in excess of 100,000 continuous acres.

    EXM currently has 10,000 cannabis plants growing on its Kuba plantation and had its first harvest at the end of 2017. Harvested products are, at this stage, dried and stored for subsequent extraction of target ingredients.

    EXM is in the final phase of obtaining licenses in other regions of the African continent, including two Agro-Industrial Parks, each of 10,000-plus acres encompassing a free trade zone.

    KUBA Plantation & Processing

    Status of Development of Production in DRC

    January 2017

    EXMceuticals obtained a license for growing psychotropic and non-psychotropic cannabis on more then 10,000 acres in DRC. Written into the contract is the potential for practically unlimited expansion of farm land.

    February/March 2017

    EXMceuticals, using locally-hired employees, cleared the land in preparation of the first cannabis crop to be planted on its DRC plantation.

    ClearingField

    December 2017

    The Kuba plantation had its first harvest. The cannabis is dried and stored for subsequent extraction of target ingredients.

    April 2018

    Specification for design and equipment acquisition is complete and the equipment ordered. The initial equipment purchase allows EXMceuticals to process in-excess-of 10,000 kg of raw cannabis per month.

    May 2018

    Hiring and training of local security crew, management and operation supervisors.

    EXMSecurityDRC.JPG

    June 2018

    Construction started on nurseries, laboratories and other ancillary facilities at the KUBA Plantation.

    July 2018

    More than 40,000 cannabis plants are in the ground and more then 10,000 plants have been harvested.

    August 2018

    Increased our labour force to clear an additional 50 acres of farm land. There will be subsequent regular increases to meet market demands.

  • Lisbon

    Portugal

    EXMceuticals is applying for a license in Portugal for the establishment of a laboratory for research, a nursery and center for processing and distribution. In addition to its more scientific mandate, the facility will be used by EXM as its base for distribution in Europe.

  • Vancouver

    Canada

    EXMceuticals has a contract with GFR Pharma Inc in Vancouver’s suburb of Coquitlam. GFR Pharma and EXM has established a joint venture company which has filed to obtain a license from Health Canada to import and distribute cannabinoid ingredients, as well as produce white label retail products containing cannabinoid ingredients, through GFR Pharma facilities. GFR Pharma is a pre-eminent full-service contract manufacturer, packager and formulation expert of superior quality tablet, capsule, powder, and liquid natural health products for the Canada and the U.S.

Democratic Republic of the Congo (DRC)

EXMceuticals, through a subsidiary, holds a license in the Kuba Kingdom, Democratic Republic of Congo, for the cultivation of cannabis and hemp, and processing and export of high-grade pharmaceutical cannabinoid ingredients. For its Kuba plantation, EXM has 10,000 acres of organic farmland and expansion rights representing in excess of 100,000 continuous acres.

EXM currently has 10,000 cannabis plants growing on its Kuba plantation and had its first harvest at the end of 2017. Harvested products are, at this stage, dried and stored for subsequent extraction of target ingredients.

EXM is in the final phase of obtaining licenses in other regions of the African continent, including two Agro-Industrial Parks, each of 10,000-plus acres encompassing a free trade zone.

KUBA Plantation & Processing

Status of Development of Production in DRC

January 2017

EXMceuticals obtained a license for growing psychotropic and non-psychotropic cannabis on more then 10,000 acres in DRC. Written into the contract is the potential for practically unlimited expansion of farm land.

February/March 2017

EXMceuticals, using locally-hired employees, cleared the land in preparation of the first cannabis crop to be planted on its DRC plantation.

ClearingField

December 2017

The Kuba plantation had its first harvest. The cannabis is dried and stored for subsequent extraction of target ingredients.

April 2018

Specification for design and equipment acquisition is complete and the equipment ordered. The initial equipment purchase allows EXMceuticals to process in-excess-of 10,000 kg of raw cannabis per month.

May 2018

Hiring and training of local security crew, management and operation supervisors.

EXMSecurityDRC.JPG

June 2018

Construction started on nurseries, laboratories and other ancillary facilities at the KUBA Plantation.

July 2018

More than 40,000 cannabis plants are in the ground and more then 10,000 plants have been harvested.

August 2018

Increased our labour force to clear an additional 50 acres of farm land. There will be subsequent regular increases to meet market demands.

Lisbon, Portugal

EXMceuticals is applying for a license in Portugal for the establishment of a laboratory for research, a nursery and center for processing and distribution. In addition to its more scientific mandate, the facility will be used by EXM as its base for distribution in Europe.

Vancouver, BC, Canada

EXMceuticals has a contract with GFR Pharma Inc in Vancouver’s suburb of Coquitlam (www.gfrpharma.com). GFR Pharma and EXM has established a joint venture company which has filed to obtain a license from Health Canada to import and distribute cannabinoid ingredients, as well as produce white label retail products containing cannabinoid ingredients, through GFR Pharma facilities. GFR Pharma is a pre-eminent full-service contract manufacturer, packager and formulation expert of superior quality tablet, capsule, powder, and liquid natural health products for the Canada and the U.S.